Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06187636
Other study ID # PHOTOHOPE
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date January 30, 2024
Est. completion date October 2025

Study information

Verified date April 2024
Source St. Jude Children's Research Hospital
Contact Alexandra Superdock, MD
Phone 866-278-5833
Email referralinfo@stjude.org
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In this study, researchers will use Photovoice to learn about how bereaved parents felt and thought about hope when their children were on hospice. 'Photovoice' is a research method that uses participants' photographs as a springboard for discussion. Primary Objective - To explore reflections, emotions, and experiences evoked in bereaved parents when reviewing photographs from their child's time on hospice, with photos selected by parents based on a prompt related to their thoughts about hope during that time.


Description:

Using a prospective qualitative design, we will enroll parents of children who died on hospice 6-24 months prior. Parents who opt to participate in the study will be asked to review photographs they have from when their child was on hospice and to select 1-5 photographs that communicate what hope meant to them at that time. Their photograph selection will be guided by a brief conversation with the researcher and a written guide that encourages the participant to think about hope broadly and invites an open interpretation of what it means for a photograph to represent hope. Parents will bring their selected photograph(s) to a one-on-one semi-structured interview. The interview will take place either in person or over a virtual meeting platform. During the interview, the participant will share the photographs with the researcher, discuss why they were chosen, and share any other reflections they have about their experience. It is anticipated that the interview will last about 60 minutes. The audio for the meeting will be recorded. Video will not be recorded.


Recruitment information / eligibility

Status Recruiting
Enrollment 25
Est. completion date October 2025
Est. primary completion date April 2025
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Participants must be the parent of a child who: - Received any form of care from a clinician at St. Jude, as documented in the electronic medical record, AND - Was enrolled on hospice at the time of death, AND - Died at least 6 months prior to enrollment, but no more than 24 months prior to enrollment. - Participants must also: - Be = 18 years of age or legally emancipated, AND - Be English-speaking or Spanish-speaking. Exclusion Criteria: - Insufficient comfort or fluency with either English or Spanish language.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States St. Jude Children's Research Hospital Memphis Tennessee

Sponsors (1)

Lead Sponsor Collaborator
St. Jude Children's Research Hospital

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Qualitative assessment of reflections, emotions, and experiences evoked in bereaved parents when reviewing photographs from their child's time on hospice The unit of analysis will be the semi-structured interview, including the transcript and any field notes taken by the researcher during or immediately after each interview. Interviews will be recorded, transcribed, de-identified, and analyzed using qualitative inductive content analysis. Content analysis will include memo-writing, codebook development, coding, reconciliation, and synthesis to identify meaningful patterns and themes. MAXQDA, a sophisticated qualitative analysis software system, will be used to conduct and synthesize analysis. Approximately 1- 3 weeks after enrollment (The time frame will be flexible to allow for maximal convenience to the participant, with participants empowered to select an interview date outside of the timeframe at their discretion.)
See also
  Status Clinical Trial Phase
Completed NCT02886052 - Internet-based Cognitive Behavior Therapy for Insomnia for Parents Who Have Lost a Child N/A
Completed NCT01453699 - Long-term Consequences of Bereavement in Children, Adolescents and Young Adults N/A
Completed NCT05655741 - Modified Delphi for Genomic Bereavement Care
Completed NCT00001913 - The Impact of Familiarity and Emotional Attachment on the Visual Processing of Faces N/A
Enrolling by invitation NCT06150859 - Ayahuasca Assisted Psychotherapy for Grief Phase 2
Completed NCT04254718 - Digital Storytelling in the NICU N/A
Completed NCT02631291 - Promoting Widowed Elders Lifestyle After Loss N/A
Recruiting NCT06191484 - Risk and Resilience to Suicide Following Late-Life Spousal Bereavement N/A
Completed NCT05156346 - Pragmatic RCT to Assess the Effectiveness of an Online Self-help Programme for Older Adults After Spousal Bereavement N/A
Completed NCT02112084 - An Individualized Grief Intervention for Spouses of Cancer Patients After the Patient's Death N/A
Recruiting NCT06047808 - Feasibility Study of the Storytelling Through Music Intervention With Bereaved Parents N/A
Recruiting NCT06136260 - The Missing Pieces Trial: A Comparison of Two Interventions to Support Parents After Their Child's Unexpected or Traumatic Death N/A
Recruiting NCT05142605 - Evaluation of Grief Therapy Approaches for Bereaved Parents N/A
Completed NCT04929405 - Pilot Testing ADAPT a Bereavement Care Intervention N/A
Enrolling by invitation NCT06302283 - Collateral Effects of Pandemics - Care for Informal Caregivers
Completed NCT02672800 - A Psychosocial Intervention for Bereaved Spousal Caregivers of Persons With Dementia N/A
Completed NCT01179568 - A Study of Medication With or Without Psychotherapy for Complicated Grief Phase 2
Completed NCT04505904 - Oxytocin and Approach-avoid in Grief N/A
Completed NCT04602520 - Preserving Compassionate End of Life Care in the Pandemic
Recruiting NCT05803499 - Rest to Overcome Loss and Reduce Risk N/A